These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36419862)

  • 1. Twelve months clinical outcomes of ultrathin strut sirolimus-eluting stent in real-world Indian patients with coronary artery disease.
    Ajmera P; Pothineni R; Chawla KK; Mantravadi SS; Jariwala P; Vijan V; Vijan V
    Am J Cardiovasc Dis; 2022; 12(5):262-271. PubMed ID: 36419862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Use Of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes.
    Ajmera P; Pothineni R; Chawla KK; Mantravadi SS; Jariwala PV; Vijan V; Vijan V
    Vasc Health Risk Manag; 2019; 15():439-447. PubMed ID: 31695399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups.
    Pothineni RB; Vijan V; Potdar A; Inamdar MK; Pathak A; Mantravadi SS; Ajmera P
    Anatol J Cardiol; 2021 Oct; 25(10):706-715. PubMed ID: 34622785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry.
    Hudec M; Kupec A; Gazdic P
    Anatol J Cardiol; 2024 Mar; 28(3):142-149. PubMed ID: 38419511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year Outcomes of Biodegradable Polymer-coated Sirolimus-eluting Coronary Stent in Acute Coronary Syndrome - A Patient-level Pooled Analysis from Two Indian Registries.
    Pothineni RB; Ajmera P; Chawla KK; Mantravadi SS; Pathak A; Inamdar MK; Jariwala PV; Vijan V; Vijan V; Potdar A
    Cardiology; 2024 May; ():. PubMed ID: 38714182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients.
    Sinha SK; Aggarwal P; Pandey U; Razi M; Kumar A; Krishna V
    Anatol J Cardiol; 2021 Feb; 25(2):111-119. PubMed ID: 33583818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries.
    Babu Pothineni R; Ajmera P; Chawla KK; Mantravadi SS; Pathak A; Inamdar MK; Jariwala PV; Vijan V; Vijan V; Potdar A
    Cureus; 2023 Jul; 15(7):e41743. PubMed ID: 37575772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine-Months Clinical Outcome of Biodegradable Polymer Coated Sirolimus-eluting Stent System: A Multi-Centre "Real-World" Experience.
    Sarma R; Prajapati J; Raheem A; Thakkar K; Kothari S; Thakkar A
    J Clin Diagn Res; 2015 Aug; 9(8):OC23-6. PubMed ID: 26435986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-month clinical outcomes of "nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 µm) sirolimus-eluting coronary stents.
    Sinha SK; Kumar P; Pandey U; Aggarwal P; Razi M; Sharma AK; Jha M; Sachan M; Shukla P; Thakur R; Krishna V; Mukherjee P; Karmakar S; Bhattacharjee P; Ray S
    Minerva Cardiol Angiol; 2023 Feb; 71(1):51-60. PubMed ID: 35212507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).
    Kasturi S; Polasa S; Sowdagar MA; Kumar P; Reddy T; Nichenamatla C; Singh S; Reddy V
    Anatol J Cardiol; 2022 Aug; 26(8):619-628. PubMed ID: 35924288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
    Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.
    Kandzari DE; Koolen JJ; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    JACC Cardiovasc Interv; 2022 Sep; 15(18):1852-1860. PubMed ID: 36137689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months' results from the S-FLEX UK registry.
    Choudhury A; Garg S; Smith J; Sharp A; Nabais de Araujo S; Chauhan A; Patel N; Wrigley B; Chattopadhyay S; Zaman AG
    BMJ Open; 2019 Oct; 9(10):e026578. PubMed ID: 31604782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
    Zbinden R; Piccolo R; Heg D; Roffi M; Kurz DJ; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Franzone A; Eberli F; Jüni P; Windecker S; Pilgrim T
    J Am Heart Assoc; 2016 Mar; 5(3):e003255. PubMed ID: 26979080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 µm) Sirolimus-Eluting Stents in Real-World Clinical Practice.
    Chandwani P; Meel B; Singhal R; Jangid K; Ahmed R; Yadav M; Gupta AK; Chopra R
    Ann Acad Med Singap; 2019 May; 48(5):150-155. PubMed ID: 31210252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.
    Kandzari DE; Koolen JJ; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1343-1353. PubMed ID: 32499026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
    Abhyankar A; Abizaid A; Chamié D; Rathod M
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):423-430. PubMed ID: 32243050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.
    Cassese S; Ndrepepa G; Byrne RA; Kufner S; Lahmann AL; Mankerious N; Xhepa E; Laugwitz KL; Schunkert H; Fusaro M; Kastrati A; Joner M
    EuroIntervention; 2018 Jun; 14(2):224-231. PubMed ID: 29537375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
    Iglesias JF; Heg D; Roffi M; Tüller D; Noble S; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Häner J; Jüni P; Windecker S; Pilgrim T
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e008024. PubMed ID: 31525083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.